Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study

被引:502
作者
Blumberg, HM
Jarvis, WR
Soucie, JM
Edwards, JE
Patterson, JE
Pfaller, MA
Rangel-Frausto, MS
Rinaldi, MG
Saiman, L
Wiblin, RT
Wenzel, RP
机构
[1] Emory Univ, Sch Med, Div Infect Dis, Dept Med, Atlanta, GA 30303 USA
[2] Grady Mem Hosp, Dept Epidemiol, Atlanta, GA USA
[3] Ctr Dis Control & Prevent, Hosp Infect Program, Atlanta, GA USA
[4] Emory Univ, Rollins Sch Publ Hlth, Dept Epidemiol, Atlanta, GA 30322 USA
[5] Univ Calif Los Angeles, Harbor Med Ctr, Dept Internal Med, Div Infect Dis, Los Angeles, CA 90024 USA
[6] Univ Texas, Hlth Sci Ctr, Dept Internal Med, Div Infect Dis, San Antonio, TX USA
[7] Univ Iowa, Dept Internal Med, Div Gen Internal Med, Iowa City, IA 52242 USA
[8] Univ Iowa, Dept Pathol, Div Med Microbiol, Iowa City, IA 52242 USA
[9] Inst Nacl Nutr, Div Hosp Epidemiol, Mexico City, DF, Mexico
[10] Univ Texas, Hlth Sci Ctr, Dept Pathol, Fungus Testing Lab, San Antonio, TX 78284 USA
[11] Columbia Univ, Dept Pediat, Div Infect Dis, New York, NY 10027 USA
[12] Virginia Commonwealth Univ, Med Coll Virginia, Dept Internal Med, Richmond, VA 23298 USA
关键词
D O I
10.1086/321811
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To assess risk factors for development of candidal blood stream infections (CBSIs), a prospective cohort study was performed at 6 sites that involved all patients admitted to the surgical intensive care unit (SICU) for >48 h over a 2-year period. Among 4276 such patients, 42 CBSIs occurred (9.82 CBSIs per 1000 admissions). The overall incidence was 0.98 CBSIs per 1000 patient days and 1.42 per 1000 SICU days with a central venous catheter in place. In multivariate analysis, factors independently associated with increased risk of CBSI included prior surgery (relative risk [RR], 7.3), acute renal failure (RR, 4.2), receipt of parenteral nutrition (RR, 3.6), and, for patients who had undergone surgery, presence of a triple lumen catheter (RR, 5.4). Receipt of an antifungal agent was associated with decreased risk (RR, 0.3). Prospective clinical studies are needed to identify which antifungal agents are most protective and which high-risk patients will benefit from antifungal prophylaxis.
引用
收藏
页码:177 / 186
页数:10
相关论文
共 47 条
  • [1] BECKSAGUE CM, 1993, J INFECT DIS, V167, P1247, DOI 10.1093/infdis/167.5.1247
  • [2] Trends in antifungal use and epidemiology of nosocomial yeast infections in a university hospital
    Berrouane, YF
    Herwaldt, LA
    Pfaller, MA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (03) : 531 - 537
  • [3] BROSS J, 1989, AM J MED, V87, P614, DOI 10.1016/S0002-9343(89)80392-4
  • [4] COHEN J, 1994, INTENS CARE MED, V20, P522, DOI 10.1007/BF01711909
  • [5] COX DR, 1972, J R STAT SOC B, V34, P187
  • [6] Surgical perspective on invasive Candida infections
    Dean, DA
    Burchard, KW
    [J]. WORLD JOURNAL OF SURGERY, 1998, 22 (02) : 127 - 134
  • [7] Nosocomial bloodstream infections in United States hospitals: A three-year analysis
    Edmond, MB
    Wallace, SE
    McClish, DK
    Pfaller, MA
    Jones, RN
    Wenzel, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 1999, 29 (02) : 239 - 244
  • [8] INVASIVE CANDIDA INFECTIONS - EVOLUTION OF A FUNGAL PATHOGEN
    EDWARDS, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (15) : 1060 - 1062
  • [9] Fluconazole prophylaxis prevents intra-abdominal candidiasis in high-risk surgical patients
    Eggimann, P
    Francioli, P
    Bille, J
    Schneider, R
    Wu, MM
    Chapuis, G
    Chiolero, R
    Pannatier, A
    Schilling, J
    Geroulanos, S
    Glauser, MP
    Calandra, T
    [J]. CRITICAL CARE MEDICINE, 1999, 27 (06) : 1066 - 1072
  • [10] CANDIDA SEPSIS IN SURGICAL PATIENTS
    EUBANKS, PJ
    DEVIRGILIO, C
    KLEIN, S
    BONGARD, F
    [J]. AMERICAN JOURNAL OF SURGERY, 1993, 166 (06) : 617 - 620